Drugs made by Intermune Inc. and Boehringer Ingelheim GmbH slowed progression of a lung disease with no cure that often kills people three to five years after diagnosis, according to findings reported by two studies. Bloomberg, 05/19/2014. (Also see: Pulmonary Fibrosis Research)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.